作者:
Matthew B,Pomrenze [1]
;
E Zayra,Millan [2]
;
F Woodward,Hopf [2]
;
Ronald,Keiflin [2]
;
Rajani,Maiya [1]
;
Angelo,Blasio [1]
;
Jahan,Dadgar [3]
;
Viktor,Kharazia [2]
;
Giordano,De Guglielmo [4]
;
Elena,Crawford [4]
;
Patricia H,Janak [2]
;
Olivier,George [4]
;
Kenner C,Rice [5]
;
Robert O,Messing [3]
作者单位:
Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin Austin, TX, USA.
[1]
Department of Neurology, University of California, San Francisco San Francisco, CA, USA.
[2]
Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at AustinAustin, TX, USA; Department of Neurology, University of California, San FranciscoSan Francisco, CA, USA.
[3]
Committee on The Neurobiology of Addictive Disorders, The Scripps Research Institute La Jolla, CA, USA.
[4]
Chemical Biology Research Branch, Drug Design and Synthesis Section, National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism Rockville, MD, USA.
[5]
DOI
10.3389/fnins.2015.00487
PMID
26733798
发布时间
2023-07-17